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Earlier work has shown that azidocytidine inhibits the growth and DNA synthesis of 3T6 mouse fibroblasts 
by inactivation of the enzyme ribonucleotide reductase. RNA synthesis, as measured by incorporation of 
[3H]cytidine was not affected. Here I show that azidocytidine is incorporated into RNA, but not into DNA. 
Incorporation of the analogue into RNA may under special circumstances contribute to the biological effect 
of the nucleoside. 
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1. INTRODUCTION 
Azidocytidine contains an azido (= N3) group at 
the 2’ -position of ribose and can be regarded as an 
analogue of both cytidine and deoxycytidine [11. In 
3T6 cells phosphorylation of the nucleoside by 
deoxycytidine kinase is a prerequisite for its 
biological activity [2]. The diphosphate of 
azidocytidine is a suicide inhibitor of ribo- 
nucleotide reductase from E. co/i and acts by 
scavenging the tyrosyl free radical of the B2 
subunit of this enzyme [3,4]. Also the mammalian 
reductase is inhibited by azidoCDP, probably via 
a similar mechanism [5]. 
Azidocytidine inhibits the growth of cells in 
culture. Earlier work suggested that inhibition was 
caused by interference with DNA strand elonga- 
tion [6] as well as by inhibition of ribonucleotide 
reductase [2]. More recently it was discovered that 
commercial preparations of azidocytidine were 
contaminated by trace amounts of arabino- 
sylcytosine and that this contaminant was respon- 
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sible for the observed effects on strand elongation. 
In 3T6 cells azidocytidine purified by HPLC and 
free from arabinosylcytosine inhibited DNA syn- 
thesis only indirectly by inhibition of ribo- 
nucleotide reductase [7]. 
Early on it seemed possible that azidocytidine 
might also exert its effect on DNA replication by 
incorporation into the polynucleotide. I started ex- 
periments to investigate this point but found no in- 
corporation into DNA. Instead, I discovered a 
small amount of incorporation of the analogue in- 
to RNA. 
2. MATERIALS AND METHODS 
2. I. Chemicals 
Azidocytidine and all enzymes were obtained 
from Boehringer, CszSO4 (ultrapure) from Merck. 
The labelling of azidocytidine with tritium was 
carried out by the tritium labelling service at Amer- 
sham. The crude radioactive reaction mixture was 
then adsorbed to a column of Dowex-1. After ex- 
tensive washing with water, azido[3H]cytidine 
(spec. act. 560 cpm/pmol) was eluted with 30% 
methanol. A short time before use, the nucleoside 
was purified further by HPLC on a 
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semipreparative Cis column with 20% methanol in 
the water. 
2.2. Cell growth and separation of nucleotides 
from nucleic acids 
3T6 cells were grown on 5-cm petri dishes in 
Dulbecco’s modification of Eagle’s medium con- 
taining 10% heat-inactivated horse serum to a den- 
sity of 0.7-l .O x lo6 cells/dish [8]. Parallel dishes 
were then incubated for different periods with 
azidocytidine and, after removal of medium, the 
cells were extracted with 60% methanol at - 20°C 
for 24 h [9]. The supernatant solution after cen- 
trifugation was used to determine the amount of 
azido[3H]CTP formed during incubation. To this 
purpose portions were spotted on PEI-cellulose 
plates and chromatographed in a system contain- 
ing 0.5 M LiClz in M HCOOH [lo]. 
2.3, Purification of RNA and DNA 
The cell pellet after methanol extraction was 
dissolved in 0.5 ml of 0.5% SDS in 20 mM Tris- 
HCl, pH 7.5, containing 2 mM EDTA and pro- 
teinase K (1 mg/ml). The samples were incubated 
for 2 h at 37°C and then extracted with an equal 
volume of chloroform/isoamyl alcohol (25 : 1) to 
remove proteins. RNA and DNA were precipitated 
with ethanol and the precipitates were dissolved in 
0.2 ml of 20 mM Tris-HCl, pH 7.5, containing 
2 mM EDTA. After addition of 0.2 ml formamide 
the samples were kept at 80°C for 5 min and then 
applied at room temperature to a neutral Cs~S04 
density gradient (2.5 ml saturated CszSO4 + 2.1 ml 
Tris-HCl, pH 7.5, containing 5 mM EDTA) and 
centrifuged for 60 h at 35000 rpm (20°C) in an 
SW 50.1 rotor. Fractions (0.3 ml) were collected 
from the bottom of the centrifuge tubes and por- 
tions (0.15 ml) of each fraction were precipitated 
with 10% trichloroacetic acid to measure acid in- 
soluble radioactivity. Fractions containing RNA or 
DNA were combined, equilibrated with 50 mM 
Tris-HCl (pH 7.5) on a Biogel P-30 column, and 
precipitated with ethanol. After centrifugation, the 
precipitates were dissolved in 0.1 ml of 20 mM 
Tris-HCl, pH 7.5. 
2.4. Enzymatic digestion of RNA and DNA 
Each sample containing RNA was digested in a 
final volume of 0.15 ml by addition of 5 pg each of 
RNase A and Tl, snake venom phosphodiesterase 
204 
and alkaline phosphatase in 5 mM MgC12 and 
5 mM CaC12. Incubation was for 2 h at 37°C. 
Conditions for the digestion of DNA were the 
same as for RNA, except hat DNase 1 was used in- 
stead of RNases. 
Approx. 50% of the radioactivity present in the 
combined RNA fractions of the Cs2SO4 gradient 
was recovered as nucleoside after the enzymatic 
digestion. The indentity of this material with 
azidocytidine was established by chromatography 
silica thin-layer plates with a metha- 
::I: chloroform (1: 1) mixture [lo]. 
3. RESULTS AND DISCUSSION 
In preliminary experiments I found that on in- 
cubation of 3T6 cells with azido[3H]cytidine acon- 
siderable amount of radioactivity was incor- 
porated into the RNA fraction of the cells. 
However, when enzymatic digests of RNA were 
analyzed by chromatography most of the radioac- 
tivity comigrated with cytidine and only a small 
part occupied the position of azidocytidine. It then 
became apparent that the preparation of 
azido[3H]cytidine was contaminated by [3H]- 
cytidine (fig.1). In spite of the fact that this con- 
taminant only amounted to a few tenths of a per- 
cent it influenced the outcome of the experiment 
and had to be removed. This was done routinely by 
HPLC chromatography on a semipreparative Crs 
column and all the results described below were 
obtained with the preparation of azido[3H]cytidine 
purified in this way. 
In the experiment described in fig.2 and table 1 
parallel plates of growing 3T6 cells were incubated 
for different times with 2 concentrations of 
azido[3H]cytidine. At the indicated times the 
medium was removed from the cells and the solu- 
ble nucleotide fractions were separated from the 
polynucleotides by extraction with 60% methanol 
as described in section 2. After removal of pro- 
teins, RNA and DNA were further purified and 
separated by centrifugation on Cs2SO4 density gra- 
dients (fig.2). This figure demonstrates that with 
time increasing amounts of radioactivity ac- 
cumulate at the position of RNA in the gradient. 
No similar accumulation is found at the position of 
DNA. Compared to the bandwidth of the 
ultraviolet markers the radioactivity showed a 
much broader distribution. This indicates that 3H 
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Fig. 1. Purification of azido[3H]cytidine by reversed- 
(2), well separated from azidocytidine (3). 
phase chromatography on a Cl8 column. ‘H-labelled 
azidocytidine purified by chromatography on Dowex-1 
was chromatographed on a semipreparative Cts column 
with 20% methanol in water. The flow rate was 
3 ml/min. Absorbance was recorded at 254 nm. The two 
main impurities are 2-amino-cytidine (1) and cytidine 
was incorporated into RNA of low Mr. Since we 
show below that isotope was incorporated as 
azidocytidine into RNA a possible explanation ap- 
pears to be that azidocytidine acts as a chain ter- 
minator. Such a result was previously found when 
azidoCTP was incorporated by primase into the 
RNA priming DNA synthesis in E. coli [l 11. 
The amount of azidocytidine incorporated into 
RNA can be calculated from the total amount of 
radioactivity present in the RNA peak, making the 
reasonable assumption that the specific activity of 
the incorporated azidocytidine is identical to that 
of azidocytidine in the medium. Table 1 compares 
the amounts of azidocytidine incorporated into 
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Fig.2. Separation on neutral CszSO4 density gradients of 
RNA and DNA labelled from azido[3H]cytidine. The 
and DNA. 
nucleic acids were labelled by incubation of growing 3T6 
cells with 53,uM azido[3H]cytidine (panels A-C) or 
158pM azido[3H]cytidine (panels D-F) for the 
indicated times. Fractions were collected from the 
bottom of centrifuge tubes and analyzed for isotope. 
The broken line in panel C shows the analysis of the 
absorbance at 260 nm corresponding to carrier RNA 
RNA at different time points and at 2 concentra- 
tions of azidocytidine with the corresponding 
amounts of azidoCTP present in the nucleotide 
fraction. It appears that incorporation into RNA is 
strongly dependent on the concentration of 
azidoCTP and always only amounts to a small 
fraction of the free nucleotide. At most, only 
10 pmol azidocytidine are incorporated into RNA 
during a 4 h period into lo6 cells. For comparison 
we estimate from previous experiments [7] that 
these cells during 4 h incorporate 20 nmol CMP. It 
is, however, possible that only a particular subset 
of RNA molecules contains azidoCMP. A second 
point emerging from the table is that the increase 
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Volume 193, number 2 FEBS LETTERS December 1985 
Table 1 
Distribution between azidoCTP and RNA (azidoCMP) 
of azido[3H]cytidine incorporated by 3T6 cells 
Azidocytidine 
in medium 
01M) 
Incubation AzidoCTP AzidoCMP 
time (pmol/106 in RNA 
(h) cells) (pmol/106 
cells) 
53 1 73.5 0.2 
53 4 201 1.45 
53 8 368 3.1 
158 1 180 0.65 
158 4 756 5.2 
158 8 1484 14.8 
The RNA values were calculated from the CszS04 
experiment described in fig.2. The azidoCTP values 
were obtained from PEI cellulose chromatograms of the 
methanolic extract 
of the amount of azidoCTP formed is essentially 
linear with time. 8 h after addition of 158 PM 
azidocytidine 3T6 cells contain approximately 
equal amounts of azidoCTP and CTP. 
To determine whether azidocytidine was incor- 
porated directly into RNA, growing 3T6 cells were 
incubated for 20 h with 0.2 or 0.8 mM 
azido[3H]cytidine and RNA and DNA were ex- 
tracted and purified by C&O4 density centrifuga- 
tion as described above (not shown). The radioac- 
tive materials were then degraded enzymatically 
and chromatographed on silica thin-layer plates as 
described in section 2. The results from the TLC 
analysis of RNA are shown in fig.3. Clearly the 
radioactivity from the RNA digest cochroma- 
tographed with authentic azidocytidine. Too little 
radioactivity was present in DNA to give meaning- 
ful results. 
While this work demonstrates that very small 
amounts of azidocytidine are incorporated into 
RNA it is not clear whether such an effect con- 
tributes to the inhibition of cell growth by the 
nucleoside analogue. Incorporation into RNA is 
minute at concentrations of azidocytidine that give 
a profound inhibition of ribonucleotide reductase. 
Overall RNA synthesis, as measured by incorpora- 
tion of [3H]cytidine, is not effected. All this might 
argue against the importance of the incorporation 
into RNA. However, it cannot be excluded that in- 
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Fig.3. Chromatography on silica thin-layer plates of an 
RNA digest. The RNA fractions from a Cs2SO4 
separation of the nucleic acids from cells labelled with 
azido[3H]cytidine was digested to nucleosides and 
separated on a silica TLC plate. The radioactivity on 
each 1 cm area was determined. The arrows indicate the 
positions of various marker nucleosides: C (cytosine), 
CR (cytidine), azidoC (azidocytidine) and azidoU 
(azidouridine). 
corporation occurs into a subset of RNA molecules 
and may contribute to the effects of the analogue. 
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